Correlation Between PacifiCorp and Catalyst Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PacifiCorp and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PacifiCorp and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PacifiCorp and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on PacifiCorp and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PacifiCorp with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PacifiCorp and Catalyst Pharmaceuticals.

Diversification Opportunities for PacifiCorp and Catalyst Pharmaceuticals

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between PacifiCorp and Catalyst is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding PacifiCorp and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and PacifiCorp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PacifiCorp are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of PacifiCorp i.e., PacifiCorp and Catalyst Pharmaceuticals go up and down completely randomly.

Pair Corralation between PacifiCorp and Catalyst Pharmaceuticals

Assuming the 90 days horizon PacifiCorp is expected to generate 5.98 times more return on investment than Catalyst Pharmaceuticals. However, PacifiCorp is 5.98 times more volatile than Catalyst Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.11 per unit of risk. If you would invest  11,350  in PacifiCorp on September 4, 2024 and sell it today you would earn a total of  2,650  from holding PacifiCorp or generate 23.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.4%
ValuesDaily Returns

PacifiCorp  vs.  Catalyst Pharmaceuticals

 Performance 
       Timeline  
PacifiCorp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PacifiCorp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting essential indicators, PacifiCorp displayed solid returns over the last few months and may actually be approaching a breakup point.
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

PacifiCorp and Catalyst Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PacifiCorp and Catalyst Pharmaceuticals

The main advantage of trading using opposite PacifiCorp and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PacifiCorp position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.
The idea behind PacifiCorp and Catalyst Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing